Letters sent to shareholders as per Reg 36
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech has sent letters to shareholders who have not registered their email IDs, sharing a weblink to view the Notice of the 40th Annual General Meeting and the Annual Report for FY 2024-25. The documents are hosted on the company's website and also available on the BSE website. This is part of SEBI's Green Initiative, which encourages electronic delivery of shareholder communications. The filing also reminds shareholders about a special SEBI window (July 7, 2025 to January 6, 2026) for re-lodging old physical share transfer requests that were rejected or left unattended before April 1, 2019. Shareholders can contact the company's RTA, RCMC Share Registry, for assistance.
This is a routine regulatory compliance filing with no direct impact on share price or business operations. Shareholders who have not updated their email addresses should do so through their Depository Participant to receive future communications smoothly.